S&P Global Ratings revises outlook on Glenmark to ‘negative’

The rating agency believes that given its soft operating performance, Glenmark will have to implement strategic measures – such as the monetisation of its active pharmaceutical ingredient business or the NCE portfolio – to substantially bring down its leverage.

from The Financial ExpressThe Financial Express https://ift.tt/30aM8Ky
via IFTTT